NCT06085924View on ClinicalTrials.gov

A Study to Learn About Effects of Living With COVID-19 and the Use of the Medicines Nirmatrelvir-Ritonavir in Treating COVID-19.

RecruitingOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

November 7, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
COVID-19
Interventions
DRUG

SoC

COVID-19 treatment as per government guidance

OTHER

Disease description

No intervention

Trial Locations (1)

110016

RECRUITING

Pfizer Limited, Taipei

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY